Interestingly in healthy individuals and in myeloid neoplasms without associated stromal changes, osteonectin expression was confined to MKs.50 In contrast, in cases with significant stromal changes (such as PMF), osteonectin reactivity extends to stromal cells. The gene discussed is SPARC; the disease is myeloid neoplasm.